1Tobin MJ.Tuberculosis,lung infections,interstitial lung diseases,social issues and journalology in AJRCCM2003[J]. Am J Respir Crit Care Med,2004,169: 288 - 330
2Tobin MJ. Astham, airway biology, and nasal disorders in AJRCCM2003 [J]. Am J Respir Crit Care Med, 2004,169:265 - 276
3Tobin MJ. Chronic obstructive pulmonary disease, pollution, pulmonary vascular disease, transplantation, pleural disease, and lung cancer in AJRCCM 2003[J] .Am J Respir Crit Care Med,2004,169:301 - 313
3Gao Y. Enantioselective preparation of optically pure albuterol[ P]. US: 5399765, 1995 - 03 - 21.
4Bakale LRP. The development of routes to ( R )-albuterol hydrochloride [J ]. Speciality Chem, 1995, 15(2) :249 - 251.
5Christopher. Process for the production of optically enriched ( R )-or ( S )-albuterol [ P ]. WO: 1999/42460, 1999 - 08 - 26.
6Hong YP, Gao Y, Nie XY, et al. Asymmetric reduction of α-ketoimines with oxazaborolidine catalysts:A novel, practical approach to chiral arylethanolamines[J]. Tetrahedron Lett, 1994, 35(31) :5551 - 5554.
7Babad E, Carruthers NI, Jaret RS, et al. A short synthesis of albuterol [ J ]. Synthesis, 1988, ( 12 ) : 966 -968.
8He Wei, Liu Peng, Wang Ping-an, et al. Preparation of N-( 9-deoxy-cinehona alkaloid-9-yl) benzathidem and its application in asymmetric transfer hydrogenation[J]. Chinese J Org Chem, 2005, 25(S2) :679.
9He Wei, Liu Peng, Zhang Bang-le, et al. Efficient iridium and rhodium-catalyzed asymmetric transfer hydrogenation using 9-amino (9-deoxy) cinchona alkaloids as chiral ligands[J]. Appl Orgmet Chem, 2006, 20(5) :328 - 334.
